Gene: MTFMT
Official Full Name: mitochondrial methionyl-tRNA formyltransferaseprovided by HGNC
Gene Summary: The protein encoded by this nuclear gene localizes to the mitochondrion, where it catalyzes the formylation of methionyl-tRNA. [provided by RefSeq, Jun 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28883 | MTFMT Knockout cell line (HeLa) | Human | MTFMT | 1:3~1:6 | Negative | Online Inquiry |
KO28884 | MTFMT Knockout cell line (HCT 116) | Human | MTFMT | 1:2~1:4 | Negative | Online Inquiry |
KO28885 | MTFMT Knockout cell line (HEK293) | Human | MTFMT | 1:3~1:6 | Negative | Online Inquiry |
KO28886 | MTFMT Knockout cell line (A549) | Human | MTFMT | 1:3~1:4 | Negative | Online Inquiry |
MTFMT Gene Knockout Cell Lines are specially engineered cellular models designed to investigate the role of the MTFMT gene in biological processes and disease states. MTFMT, or mitochondrial methionyl-tRNA formyltransferase, is essential for mitochondrial protein synthesis, playing a critical role in translating this vital genetic information. By producing cell lines with targeted deletions of the MTFMT gene, these knockout models enable researchers to dissect the functional implications of this gene in live cells, thereby illuminating its contributions to mitochondrial biology and associated pathologies.
The primary function of the MTFMT Gene Knockout Cell Lines is their capacity to facilitate the study of mitochondrial dysfunctions that could contribute to various diseases, including neurodegenerative disorders and metabolic syndromes. Researchers can observe alterations in mitochondrial function, oxidative stress responses, and cell viability, leading to insights that pave the way for novel therapeutic strategies. These cells serve as robust tools for screening potential drug candidates, understanding gene interactions, and developing gene therapies.
The scientific importance of these cell lines spans fundamental research and clinical applications. They provide a revolutionary platform for elucidating the mechanisms that underlie mitochondrial diseases and can assist in the discovery of biomarkers for early diagnosis or prognosis. Unlike conventional cell models, MTFMT Gene Knockout Cell Lines specifically address the complexities of mitochondrial genetics, offering researchers tailored cellular environments that reflect the genomic deletions of interest.
Moreover, their unique selling points include high fidelity in maintaining the knockout genotype and adaptability for various experimental conditions. Researchers benefit from an optimized and enhanced experimental workflow, coupled with rigorous quality control measures implemented during the production process.
For researchers and clinicians focused on mitochondrial research or seeking to develop targeted therapeutic interventions, MTFMT Gene Knockout Cell Lines represent an essential addition to their toolkit. The insights garnered from utilizing these specialized cell lines are not only pivotal in advancing our understanding of mitochondrial biology but are also instrumental in driving innovations in treatment approaches.
Our company is dedicated to providing high-quality biological products and solutions, backed by extensive expertise in genetic engineering and cell line development. We are committed to supporting your research with reliable, innovative tools that foster scientific discovery and advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.